-
1دورية أكاديمية
المؤلفون: M.A. Maschan, G.A. Novichkova
المصدر: Вопросы современной педиатрии, Vol 8, Iss 3, Pp 66-75 (2009)
مصطلحات موضوعية: Pediatrics, RJ1-570
وصف الملف: electronic resource
-
2
المؤلفون: I.V. Mersiyanova, V. A. Vedmedskaya, M.A. Maschan, E.A. Kulakovskaya, M.S. Fadeeva, A.L. Khoreva, A.Yu. Shcherbina, E.A. Malakhova, I.S. Vladimirov, Dmitry Pershin, E.V. Raikina, Yu.A. Rodina, A. M. Kieva, O.B. Lodoeva, Immunology named after Dmitry Rogachev, Moscow, Russia
المصدر: Pediatria. Journal named after G.N. Speransky. 100:31-40
مصطلحات موضوعية: Pathology, medicine.medical_specialty, medicine.diagnostic_test, Wiskott–Aldrich syndrome, business.industry, Pediatrics, Perinatology and Child Health, medicine, In patient, macromolecular substances, medicine.disease, business, Flow cytometry
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::53d027a4fffca189cf382dab44f7fda2Test
https://doi.org/10.24110/0031-403x-2021-100-2-31-40Test -
3
المؤلفون: Svetlana Radygina, I.P. Shipitsyna, G.A. Novichkova, Anna Livshits, Alexandra Laberko, Kirill Voronin, Dmitry Balashov, Yu.V. Skvortsova, A.Yu. Shcherbina, Larisa Shelikhova, Svetlana Kozlovskaya, M.A. Maschan, Immunology named after Dmitry Rogachev, Moscow, Russia
المصدر: Pediatria. Journal named after G.N. Speransky. 99:43-51
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, medicine.medical_treatment, Internal medicine, Pediatrics, Perinatology and Child Health, medicine, In patient, Hematopoietic stem cell transplantation, Alternative donor, business, Transplant cell
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::f71e9670c41335167ae22db55c0b538aTest
https://doi.org/10.24110/0031-403x-2020-99-2-43-51Test -
4
المؤلفون: Nausheen Ahmed, Marcos de Lima, Sarah Kleinsorge Block, Folashade Otegbeye, Patricio Rojas, Jane Reese-Koc, Seema Patel, Boro Dropulic, Ashish Sharma, Kirsten M Boughan, Jennifer Schiavone, Paolo Caimi, Gabriela Pacheco Sanchez, Antoinette Hillian, M.A. Maschan, Rafick-Pierre Sekaly, Kayla Zamborsky
المصدر: Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunologyمصطلحات موضوعية: Male, Premedication, medicine.medical_treatment, Kaplan-Meier Estimate, Immunotherapy, Adoptive, Severity of Illness Index, Gastroenterology, chemistry.chemical_compound, Adrenal Cortex Hormones, Immunology and Allergy, Original Research, biology, Lymphoma, Non-Hodgkin, Middle Aged, Progression-Free Survival, Cytokine release syndrome, C-Reactive Protein, Treatment Outcome, Cytokine, Cytokines, Female, Neurotoxicity Syndromes, CAR- T cells, Lymphoma, Large B-Cell, Diffuse, prophylaxis, cytokine release syndrome (CRS), Cytokine Release Syndrome, Adult, medicine.medical_specialty, Immunology, lymphoma, Antibodies, Monoclonal, Humanized, Drug Administration Schedule, tocilizumab, Tocilizumab, Internal medicine, medicine, Humans, Adverse effect, Aged, Salvage Therapy, Chemotherapy, business.industry, C-reactive protein, RC581-607, medicine.disease, Receptors, Interleukin-6, Chimeric antigen receptor, Lymphoma, Interleukin 1 Receptor Antagonist Protein, chemistry, Ferritins, biology.protein, Immunologic diseases. Allergy, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::647f1575b2c38ac5866b33b74201e962Test
https://www.frontiersin.org/articles/10.3389/fimmu.2021.745320/fullTest -
5دورية أكاديمية
المؤلفون: M.A. Maschan, G.A. Novichkova, М.А. Масчан, Г.А. Новичкова
المصدر: Current Pediatrics; Том 8, № 3 (2009); 66-75 ; Вопросы современной педиатрии; Том 8, № 3 (2009); 66-75 ; 1682-5535 ; 1682-5527
العلاقة: Favara B.E. Hemophagocytic lymphohistiocytosis: a hemophagocytic syndrome. Semin.Diagn.Pathol. 1992; 9 (1): 63–74.; Новичкова Г.А., Минков М., Масчан М.А., Чернов В.М. Гистиоцитозы в кн. Клиническая онкогематология. Под ред. М.А.Волковой. М. 2007.; Arceci R.J. When T cells and macrophages do not talk: the hemophagocytic syndromes. Curr.Opin.Hematol. 2008; 15 (4): 359–367.; Farquhar J.W., Claireaux A. E. Familial haemophagocytic reticulosis. Arch.Dis.Child. 1952; 27 (136): 519–525.; Filipovich A.H. Hemophagocytic lymphohistiocytosis: a lethal disorder of immune regulation. J.Pediatr. 1997; 130 (3): 337–338.; Henter J.I. Biology and treatment of familial hemophagocytic lymphohistiocytosis: importance of perforin in lymphocyte-mediated cytotoxicity and triggering of apoptosis. Med.Pediatr.Oncol. 2002; 38 (5): 305–309.; Voskoboinik I., Smyth M.J., Trapani J.A. Perforin-mediated target-cell death and immune homeostasis. Nat.Rev.Immunol. 2006; 6 (12): 940–952.; Henter J.I., Elinder G., Soder, O. et al. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood. 1991; 78 (11): 2918–2922.; Osugi Y. Hara J., Tagawa S. et al. Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood. 1997; 89 (11): 4100–4103.; JordanM., Filipovich A.H. Hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis: a journey of a thousand miles begins with a single (big) step. Bone Marrow Transplant. 2008; 42 (7): 433–437.; Dufourcq-Lagelouse R., Jabado N., Deist F.et al. Linkage of familial hemophagocytic lymphohistiocytosis to 10q21-22 and evidence for heterogeneity. Am. J. Hum. Genet. 1999; 64 (1): 172–179.; Ohadi M., Lalloz M.R., Sham P. et al. Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping. Am. J. Hum. Genet. 1999; 64 (1): 165–171.; Stepp S.E., Dufourcq–Lagelouse R., Deist F. et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science.1999; 286 (5446): 1957–1959.; Stadt U., Schmidt S., Kasper B. et al. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type 4 to chromosome 6q24 and identification of mutations in syntaxin 1. Hum.Mol.Genet. 2005; 14 (6): 827–834.; Feldmann J., Callebaut I., Raposo G. et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell. 2003; 115 (4): 461–473.; Henter J.I., Elinder G., Soder O. Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis. Acta Paediatr.Scand. 1991; 80 (4): 428–435.; Arico M., Janka G., Fischer A.et al. Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. Leukemia. 1996; 10 (2): 197–203.; Janka G. E. Familial hemophagocytic lymphohistiocytosis. Eur. J. Pediatr. 1983; 140 (3): 221–230.; Haddad E., Sulis M.L., Jabado N. et al. Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis. Blood. 1997; 89 (3): 794–800.; Henter J. I., Elinder G., Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin. Oncol. 1991; 18 (1): 29–33.; Egeler R.M., Shapiro R., Loechelt B. Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis. J.Pediatr.Hematol.Oncol.1996; 18 (4): 340–345.; Kogawa K., Lee S. M., Villanueva J. et al. Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. Blood. 2002; 99 (1): 61–66.; Marcenaro S., Gallo F., Martini S. et al. Analysis of natural killer-cell function in familial hemophagocytic lymphohistiocytosis (FHL): defective CD107a surface expression heralds Munc13–4 defect and discriminates between genetic subtypes of the disease. Blood. 2006; 108 (7): 2316–2323.; Nezelof C. Hemophagocytic lymphohistiocytosis as a syndrome: correlation of clinicopathological data. Pediatr .Hematol. Oncol. 1989; 6 (3): 207–211.; Henter J.I. Nennesmo, I. Neuropathologic findings and neurologic symptoms in twenty-three children with hemophagocytic lymphohistiocytosis. J. Pediatr.1997; 130 (3): 358–365.; Henter J.I., Horne A., Arico M. et al. HLH–2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr. Blood Cancer. 2007; 48 (2): 124–131.; Imashuku S. Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment. Int. J. Hematol. 1997; 66 (2): 135–151.; Henter J.I., Arico M., Egeler R.M. et al. HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. Med. Pediatr. Oncol. 1997; 28 (5): 342–347.; Henter J.I., Samuelsson–Horne A., Aric M. et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood. 2002; 100 (7): 2367–2373.; Mahlaoui N., Ouachee-Chardin M. et al. Immunotherapy of familial hemophagocytic lymphohistiocytosis with anti–thymocyte globulins: a single center retrospective report of 38 patients. Pediatrics. 2007; 120 (3): 622–628.; Adachi S., Kubota M., Akiyama Y. et al. Successful bone marrow transplantation from an HLA-identical unrelated donor in a patient with hemophagocytic lymphohistiocytosis. Bone Marrow Transplant.1997; 19 (2): 183–185.; Baker K.S., Delaat C.A., Steinbuch M. et al. Successful correction of hemophagocytic lymphohistiocytosis with related or unrelated bone marrow transplantation. Blood.1997; 89 (10): 3857–3863.; Jabado N., de Graeff–Meeder E.R., Cavazzana-Calvo M. et al. Treatment of familial hemophagocytic lymphohistiocytosis with bone marrow transplantation from HLA genetically nonidentical donors. Blood. 1997; 90 (12): 4743–4748.; Ouachee-Chardin M., Elie C. et al. Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: a single center report of 48 patients. Pediatrics. 2006; 117 (4): 743–750.; Cooper N., Rao K., Gilmour K. et al. Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis. Blood. 2006; 107 (3): 1233–1236.; Janka G., Imashuku S., Elinder G. et al. Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol. Oncol. Clin. North Am.1998; 12 (2): 435–444.; Risdall R.J., McKenna R.W., Nesbit M.E. et al. Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer.1979; 44 (3): 993–1002.; Fisman D.N. Hemophagocytic syndromes and infection. Emerg. Infect. Dis. 2000; 6 (6): 601–608.; Asci G., Toz H., Ozkahya M. et al. High dose immunoglobulin therapy in renal transplant recipients with hemophagocytic histiocytic syndrome. J. Nephrol. 2006; 19 (3): 322–326.; Kasahara Y., Yachie A., Takei K. et al. Differential cellular targets of Epstein–Barr virus (EBV) infection between acute EBV–associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood. 2001; 98 (6): 1882–1888.; Kasahara Y., Yachie A. Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Crit. Rev. Oncol. Hematol. 2002; 44 (3): 283–294.; Kawaguchi H., Miyashita T., Herbst H. et al. Epstein–Barr virus-infected T lymphocytes in Epstein–Barr virus–associated hemophagocytic syndrome. J. Clin. Invest. 1993; 92 (3): 1444–1450.; Imashuku S., Hibi S., Ohara T. et al. Effective control of Epstein-Barr virus related hemophagocytic lymphohistiocytosis with immunochemotherapy. Histiocyte Society. Blood. 1999; 93 (6): 1869–1874.; Imashuku S., Kuriyama K., Teramura T. et al. Requirement for etoposide in the treatment of Epstein–Barr virus–associated hemophagocytic lymphohistiocytosis. J. Clin. Oncol. 2001; 19 (10): 2665–2673.; Myers T.J., Kessimian N., Schwartz S. Mediastinal germ cell tumor associated with the hemophagocytic syndrome. Ann .Intern. Med. 1988; 109 (6): 504–505.; Nakamoto T., Ogawa S., Mano H. et al. Hemophagocytic syndrome associated with non-Hodgkin's lymphoma of B–cell type. Am. J. Hematol. 1994; 47 (4): 335–336.; Okada Y., Nakanishi I., Nomura H. et al. Angiotropic B-cell lymphoma with hemophagocytic syndrome. Pathol. Res. Pract. 1994; 190 (7): 718–724.; Takahashi N., Miura I., Chubachi A. et al. A clinicopathological study of 20 patients with T/natural killer (NK)–cell lymphoma associated hemophagocytic syndrome with special reference to nasal and nasal type NK/T-cell lymphoma. Int. J. Hematol. 2001; 74 (3): 303–308.; Chin M., Mugishima H., Takamura M. et al. Hemophagocytic syndrome and hepatosplenic gammadelta T–cell lymphoma with isochromosome 7q and 8 trisomy. J. Pediatr. Hematol. Oncol. 2004; 26 (6): 375–378.; Shimazaki C., Inaba T., Nakagawa M. B-cell lymphoma-associated hemophagocytic syndrome. Leuk. Lymphoma.2000; 38 (1–2): 121–130.; Grom A.A. Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities? Curr. Opin.Rheumatol. 2003; 15 (5): 587–590.; Morris J.A., Adamson A.R., Holt P.J. Still's disease and the virus-associated haemophagocytic syndrome. Ann. Rheum. Dis. 1985; 44 (5): 349–353.; Prieur A.M., Fischer A. Griscelli C. Still's disease and haemophagocytic syndrome. Ann. Rheum. Dis. 1985; 44 (11): 806.; Cortis E., Insalaco A. Macrophage activation syndrome in juvenile idiopathic arthritis. Acta Paediatr.Suppl. 2006; 95 (452): 38–41.; Grom A.A. Natural killer cell dysfunction: A common pathway in systemic onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis? Arthritis Rheum.2004; 50 (3): 689–698.; https://vsp.spr-journal.ru/jour/article/view/1119Test
-
6دورية أكاديمية
المؤلفون: M.A. Maschan, N.V. Poltavets, М.А. Масчан, Н.В. Полтавец
المصدر: Pediatric pharmacology; Том 8, № 2 (2011); 15-21 ; Педиатрическая фармакология; Том 8, № 2 (2011); 15-21 ; 2500-3089 ; 1727-5776
-
7دورية أكاديمية
المؤلفون: M.A. Maschan, N.V. Poltavets
المصدر: Pediatričeskaâ Farmakologiâ, Vol 8, Iss 2, Pp 15-21 (2011)
مصطلحات موضوعية: Therapeutics. Pharmacology, RM1-950
-
8
المؤلفون: E.V. Raykina, Larisa Shelikhova, Z.B. Shekhovtsova, V.V. Brilliantova, D.N. Balashov, M.A. Maschan, K.А. Voronin, A.L. Laberko, R.P. Pirumova, Elena Kurnikova, E V Boyakova, А.А. Bogoyavlenskaya
المصدر: Voprosy gematologii/onkologii i immunopatologii v pediatrii. 16:10-21
مصطلحات موضوعية: biology, business.industry, medicine.medical_treatment, Immunology, Hematology, Hematopoietic stem cell transplantation, CD19, Oncology, Pediatrics, Perinatology and Child Health, Herpesvirus infection, biology.protein, Immunology and Allergy, Medicine, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::6d10d4b1c5d67308670a7c37483a5f1eTest
https://doi.org/10.24287/1726-1708-2017-16-1-10-21Test -
9
المؤلفون: I.V. Ivanova, A.S. Zinchenko, G.A. Novichkova, N.P. Leonov, E.A. Spiridonova, M.A. Maschan, K.R. Gasparyan, V.V. Shchukin
المصدر: Anesteziologiya i reanimatologiya. :118
مصطلحات موضوعية: medicine.medical_specialty, Anesthesiology and Pain Medicine, Blood pressure, business.industry, Internal medicine, Non invasive, Emergency Medicine, medicine, Cardiology, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::38c5026198ad23b6f68d2292643638e9Test
https://doi.org/10.17116/anaesthesiology2021041118Test -
10
المؤلفون: I.P. Shipitsyna, A.Yu. Shcherbina, Alexandra Laberko, Alexey Maschan, Elena Gutovskaya, G.A. Novichkova, Yu.A. Rodina, S.A. Dibirova, E.V. Deripapa, Dmitriy Balashov, I.G. Khamin, Larisa Shelikhova, M.A. Maschan, I.N. Smirnova, Yu.V. Skvortsova
المصدر: Voprosy gematologii/onkologii i immunopatologii v pediatrii. 15:72-80
مصطلحات موضوعية: Primary (chemistry), biology, business.industry, medicine.medical_treatment, Immunology, Hematology, Hematopoietic stem cell transplantation, CD19, Oncology, Pediatrics, Perinatology and Child Health, biology.protein, Immunology and Allergy, Medicine, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::0795da1b54c67c9abf6c325519abbb98Test
https://doi.org/10.20953/1726-1708-2016-1-72-80Test